In last trading session, Biodesix Inc (NASDAQ:BDSX) saw 0.66 million shares changing hands with its beta currently measuring 1.14. Company’s recent per share price level of $0.57 trading at -$0.02 or -4.09% at ring of the bell on the day assigns it a market valuation of $83.26M. That closing price of BDSX’s stock is at a discount of -257.89% from its 52-week high price of $2.04 and is indicating a discount of -3.51% from its 52-week low price of $0.59. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.38 million shares which gives us an average trading volume of 447.31K if we extend that period to 3-months.
For Biodesix Inc (BDSX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Biodesix Inc (NASDAQ:BDSX) trade information
Upright in the red during last session for losing -4.09%, in the last five days BDSX remained trading in the red while hitting it’s week-highest on Tuesday, 04/01/25 when the stock touched $0.57 price level, adding 23.88% to its value on the day. Biodesix Inc’s shares saw a change of -62.72% in year-to-date performance and have moved -14.87% in past 5-day. Biodesix Inc (NASDAQ:BDSX) showed a performance of -32.89% in past 30-days. Number of shares sold short was 1.26 million shares which calculate 2.37 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 3 to the stock, which implies a rise of 81.0% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 3. It follows that stock’s current price would drop -426.32% in reaching the projected high whereas dropping to the targeted low would mean a loss of -426.32% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 69.26% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 37.37% while estimates for its earnings growth in next 5 years are of 38.97%.
Biodesix Inc (NASDAQ:BDSX)’s Major holders
Insiders are in possession of 48.42% of company’s total shares while institution are holding 40.21 percent of that, with stock having share float percentage of 77.96%. Investors also watch the number of corporate investors in a company very closely, which is 40.21% institutions for Biodesix Inc that are currently holding shares of the company. TELEMARK ASSET MANAGEMENT, LLC is the top institutional holder at BDSX for having 8.28 million shares of worth $12.67 million. And as of 2024-06-30, it was holding 6.513 of the company’s outstanding shares.
The second largest institutional holder is SOLEUS CAPITAL MANAGEMENT, L.P., which was holding about 6.11 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.8062 of outstanding shares, having a total worth of $9.35 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 2.3 shares of worth $1.31 million or 1.57% of the total outstanding shares. The later fund manager was in possession of 1.42 shares on Dec 31, 2024 , making its stake of worth around $0.81 million in the company or a holder of 0.97% of company’s stock.
